Observational Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy to Assess the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant
Latest Information Update: 08 Apr 2025
At a glance
- Drugs Cannabidiol (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc
Most Recent Events
- 03 Apr 2025 Planned initiation date changed from 30 Apr 2025 to 30 Jul 2025.
- 19 Feb 2025 Planned initiation date (estimated date for recruitment of the first subject) changed from 3 Feb 2025 to 30 Apr 2025.
- 27 Dec 2024 Planned initiation date changed from 1 Dec 2024 to 3 Feb 2025.